日本語View as Markdown

Magnesium silicate nanosheets enable sustained hydrogen release to attenuate secondary brain injury following intracerebral hemorrhage.

ケイ酸マグネシウムナノシートによる持続的水素放出が脳内出血後の二次性脳損傷を軽減する

animal study mixed routes positive 3%

Abstract

Intracerebral hemorrhage (ICH) causes severe secondary brain injury through oxidative stress, neuroinflammation, and apoptosis. This study synthesized pH-responsive magnesium silicate nanosheets (MGNs) capable of sustained hydrogen release, especially under acidic conditions. In a collagenase-induced ICH mouse model, oral MGN administration produced dose-dependent improvements in neurological function, reductions in brain edema and hematoma volume, preservation of neuronal integrity, suppression of pro-inflammatory cytokines, and decreased apoptotic signaling. MGNs outperformed conventional 3% hydrogen gas inhalation in neuroprotective efficacy and demonstrated a favorable biosafety profile across systematic evaluation. These findings position MGNs as a promising nanoplatform for sustained hydrogen delivery in the context of hemorrhagic brain injury.

Mechanism

MGNs release hydrogen continuously under acidic conditions, suppressing neuronal apoptotic pathways and reducing pro-inflammatory cytokine production, thereby mitigating secondary brain injury following ICH.

Bibliographic

Authors
Ma C, Han B, Guo J, Shi CK, Liu Y, Yi WJ, et al.
Journal
J Transl Med
Year
2026 (2026-02-07)
PMID
41654898
DOI
10.1186/s12967-026-07755-5
PMC
PMC12977831

Tags

Disease:神経炎症 脳卒中・脳虚血 Delivery:水素水経口投与 Mechanism:アポトーシス抑制 炎症抑制 酸化ストレス 活性酸素種

Delivery context

This study combines multiple delivery routes. As a general principle, the most efficient route for routine hydrogen intake is inhalation. Inhalation carries explosion risk (empirical LFL of 10%; high-concentration devices are documented in the Consumer Affairs Agency accident database and are not recommended).

Safety notes

This study combines multiple delivery routes. As a general principle, the most efficient route for routine hydrogen intake is inhalation. Inhalation carries explosion risk (empirical LFL of 10%; high-concentration devices are documented in the Consumer Affairs Agency accident database and are not recommended).

See also:

Other papers on the same disease / condition

Cite as: H2 Papers — PMID 41654898. https://h2-papers.org/en/papers/41654898
Source: PubMed PMID 41654898